1. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria Chemoprevention. Issue 3 (30th May 2017) Authors: Kajubi, R; Huang, L; Jagannathan, P; Chamankhah, N; Were, M; Ruel, T; Koss, CA; Kakuru, A; Mwebaza, N; Kamya, M; Havlir, D; Dorsey, G; Rosenthal, PJ; Aweeka, FT Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 3(2017) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin‐Piperaquine for Uncomplicated Malaria. Issue 1 (2nd May 2015) Authors: Sambol, NC; Yan, L; Creek, DJ; McCormack, SA; Arinaitwe, E; Bigira, V; Wanzira, H; Kakuru, A; Tappero, JW; Lindegardh, N; Tarning, J; Nosten, F; Aweeka, FT; Parikh, S Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 1(2015:Jul.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV‐1‐infected pregnant women and relationship to antiretroviral pharmacokinetics. Issue 3 (18th November 2014) Authors: Aweeka, FT; Hu, C; Huang, L; Best, BM; Stek, A; Lizak, P; Burchett, SK; Read, JS; Watts, H; Mirochnick, M; Capparelli, EV; the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Team Journal: HIV medicine Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗